heres a little offtake from an article in regards to pre IND meetings with the FDAThe pre-IND meeting typically includes a discussion of scientific and regulatory aspects of the drug as they relate to safety and/or potential clinical hold issues. Sponsors are strongly encouraged to take advantage of the pre-IND meeting for the following reasons:
https://www.nuventra.com/resources/blog/fda-pre-ind-meeting-guide/
- -The information gained from the meeting can help ensure a complete IND application is submitted and potentially help avoid clinical holds
- -The meeting presents a formal opportunity to gather the FDA’s perspectives, recommendations, and preliminary agreement (or disagreement) on critical aspects of your development program
- -The meeting is an opportunity to build a constructive relationship with the FDA
- -No fees are required for this meeting
- source
- Forums
- ASX - By Stock
- OCC
- Ann: Notice under Section 708(A) of the Corporations Act
Ann: Notice under Section 708(A) of the Corporations Act, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.020(5.71%) |
Mkt cap ! $77.45M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 36.0¢ | $164.0K | 445.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3044 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 21526 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3044 | 0.360 |
7 | 79398 | 0.355 |
10 | 123509 | 0.350 |
4 | 119256 | 0.345 |
2 | 45000 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 21526 | 1 |
0.375 | 37488 | 2 |
0.380 | 9391 | 3 |
0.385 | 40000 | 1 |
0.390 | 28502 | 5 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |